Where AIRE we now? Where AIRE we going?

Area of Science:

• Immunology
• Genetics
• Endocrinology

Background:

• The autoimmune regulator (AIRE) gene plays a critical role in maintaining immune tolerance.
• Dysregulation of AIRE gene expression is implicated in autoimmune disorders.

Purpose of the Study:

• To review recent advancements in AIRE gene expression and its role in central and peripheral tolerance.
• To explore the implications of AIRE impairment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
• To discuss potential therapeutic strategies for AIRE-associated conditions.

Main Methods:

• Literature review of recent studies on AIRE gene function.
• Analysis of genetic mutations and polymorphisms associated with APECED.
• Examination of immunological mechanisms underlying AIRE deficiency.

Main Results:

• AIRE gene mutations are the primary cause of APECED.
• AIRE dysfunction leads to impaired T cell selection, reduced regulatory T cell function, and autoantibody production.
• Excessive interferon-γ response may drive organ damage in APECED.
• Janus kinase (JAK)-inhibitors demonstrate potential as a treatment for various manifestations.

Conclusions:

• AIRE is essential for immune tolerance; its disruption causes complex immune perturbations.
• Understanding the AIRE function-clinical phenotype correlation is vital for translational medicine.
• Targeting pathways like JAK may offer new therapeutic avenues for autoimmune diseases.